Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
677.00    10.00 (1.50%)
Bid:
676.00
Ask:
678.00
Spread: 2.00 (0.296%)
Market Cap: £589.84m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Annual Trading Update

8 Oct 2009 07:00

RNS Number : 4270A
Victrex PLC
08 October 2009
 



Thursday 8 October 2009

Victrex plc

Annual Trading Update

Victrex will announce its results for the year ended 30 September 2009 on Tuesday 8 December 2009. Today, the Company announces its regular annual trading update. 

Invibio

Invibio®, our biomaterials division, had an excellent year with revenue of approximately £34.1m, an increase of 37% over the previous year (£24.9m). At £16.5m, second half revenue was down 6% on the very strong first half (£17.6m) principally as a result of inventory rationalisation at certain customers.

 

Group sales volume

Encouragingly, monthly volumes have shown continued improvement throughout the second half due to increased Victrex Polymer Solutions sales. Following the low point of 88 tonnes in March, as previously announced, Group volume recovered to 110 tonnes in April, with a further increase to 142 tonnes in July. This level was sustained in August with a further increase to approximately 155 tonnes in September. Group sales volume for the year is therefore expected to be approximately 1,545 tonnes.

As a result of the sales volume achieved in the fourth quarter, whave increased polymer production levels and have recommenced monomer production.

Outlook

Overall, we expect profits for 2009 to be in line with market expectations.

Invibio continues to show strong sales performance and development potential. Accordingly, we expect further revenue growth in 2010.

While it is still too early to judge the extent to which the recovery in Victrex Polymer Solutions sales volume in the second half of 2009 is due to restocking or a higher level of sustainable demand, it represents a positive trend. However2010 sales volume will be highly dependent on the extent to which this recovery is sustained.

-Ends-

Enquiries

Victrex plc

Mike Peacock, Finance Director 01253 897700 

Hogarth Partnership Limited

Nick Denton / Barnaby Fry 0207 357 9477

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. The Victrex Polymer Solutions Division ('VPS') is responsible for polymer business in our major industrial markets including transport, energy and electronics. The Biomaterials Solutions Division ('Invibio') provides specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTCKOKQABDDQKK
Date   Source Headline
31st Jul 202412:20 pmRNSTotal Voting Rights
5th Jul 20242:02 pmRNSDirector/PDMR Shareholding
4th Jul 20247:00 amRNSQ3 Interim Management Statement
28th Jun 20249:52 amRNSTotal Voting Rights
24th Jun 20249:44 amRNSHolding(s) in Company
14th Jun 20249:00 amRNSAdditional Listing
3rd Jun 20242:19 pmRNSBlock listing Interim Review
3rd Jun 20249:30 amRNSDirector/PDMR Shareholding
31st May 202411:23 amRNSTotal Voting Rights
23rd May 20247:00 amRNSSBTI approval of carbon reduction targets
15th May 20243:59 pmRNSDirector/PDMR Shareholding
14th May 20244:05 pmRNSDirector/PDMR Shareholding
13th May 20247:00 amRNSVictrex plc - Interim Results 2024
7th May 20243:25 pmRNSDirector Declaration
30th Apr 20242:54 pmRNSTotal Voting Rights
28th Mar 20249:56 amRNSTotal Voting Rights
15th Mar 20248:30 amRNSDirectorate Change
6th Mar 20242:06 pmRNSDirector/PDMR Shareholding
29th Feb 20249:36 amRNSTotal Voting Rights
21st Feb 20248:00 amRNSBlock listing Interim Review
9th Feb 202412:16 pmRNSResult of AGM
9th Feb 20247:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202412:26 pmRNSTotal Voting Rights
25th Jan 202410:57 amRNSHolding(s) in Company
9th Jan 202412:13 pmRNSAnnual Report & Accounts
29th Dec 20239:00 amRNSTotal Voting Rights
12th Dec 202310:21 amRNSDirector/PDMR Shareholding
5th Dec 20232:42 pmRNSDirector/PDMR Shareholding
5th Dec 20232:33 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSVictrex plc - Preliminary Results 2023
1st Dec 202310:41 amRNSBlock listing Interim Review
30th Nov 202311:10 amRNSTotal Voting Rights
3rd Nov 20231:31 pmRNSHolding(s) in Company
31st Oct 20239:36 amRNSTotal Voting Rights
19th Sep 20231:59 pmRNSDirector/PDMR Shareholding
8th Sep 20239:32 amRNSHolding(s) in Company
31st Aug 20239:30 amRNSTotal Voting Rights
23rd Aug 202310:52 amRNSHolding(s) in Company
17th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20239:39 amRNSTotal Voting Rights
18th Jul 202311:51 amRNSDirector/PDMR Shareholding
13th Jul 20232:00 pmRNSAdditional Listing
6th Jul 20237:00 amRNSVictrex plc - Q3 Interim Management Statement
3rd Jul 20234:03 pmRNSHolding(s) in Company
30th Jun 20239:37 amRNSTotal Voting Rights
27th Jun 202310:08 amRNSDirector/PDMR Shareholding
19th Jun 20232:27 pmRNSDirector/PDMR Shareholding
14th Jun 20237:00 amRNSTrading Statement
1st Jun 202312:08 pmRNSBlock listing Interim Review
31st May 20239:52 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.